The TSX Venture Exchange has accepted for filing a secured and non-convertible loan agreement dated Oct. 20, 2025, between Zyus Life Sciences Corp.'s wholly owned subsidiary, Zyus Life Sciences Inc. (Subco), and a non-arm's-length party, Wayne Brownlee. Pursuant to the agreement, the lender advanced a secured loan for an aggregate principal amount of $500,000 to Subco. The loan matures on Oct. 31, 2027, and bears interest at a rate of 12 per cent per annum, payable on maturity.

Furthermore, the exchange has approved the issuance of 724,637 non-transferable bonus warrants to the lender, each exercisable into one common share at 69 cents per share until Oct. 31, 2027, subject to an acceleration right.

For more information, please refer to the company's news release dated Oct. 17, 2025, and Oct. 20, 2025.